FY2025 · ended Mar 31, 2025 · Revenue $24.21M, +5.0% YoY · Filed Jun 20, 2025
Cyanotech Corp (CYAN) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Mar 31, 2025, it reported revenue of $24.2 million and a net loss of $3.2 million. As of Sep 30, 2025 it held $649,000 in cash and investments and $8.2 million in total debt.
Revenue (TTM)
$24.12M
+3.1% vs year-ago TTM
Net income (TTM)
$-3.84M
-5.9% vs year-ago TTM
Operating cash flow (TTM)
$-474,000
+81.3% vs year-ago TTM
Free cash flow
$-1.28M
-363.5% vs prior year
EPS (TTM)
$-26.64
-142.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
7.23M
+4.1% vs prior year
Net cash
$-7.59M
as of Sep 30, 2025
Operating margin
-13.0%
FY 2025
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CYAN (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Kailua Kona, HI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 768408
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $24.2M | $23.1M | $23.2M | $36.0M | $32.3M |
| Operating income | -$2.5M | -$4.6M | -$2.9M | $2.6M | $84,000 |
| Net income | -$3.2M | -$5.3M | -$3.4M | $2.2M | $920,000 |
| Diluted EPS | — | -$0.81 | -$0.55 | $0.35 | $0.15 |
| Operating cash flow | -$1.2M | -$455,000 | -$2.1M | $2.4M | $2.4M |
| Total assets | $23.5M | $25.1M | $29.7M | $32.0M | $30.9M |
| Total liabilities | $14.6M | $13.3M | $13.4M | $12.6M | $13.8M |
| Stockholders' equity | $8.9M | $11.8M | $16.3M | $19.5M | $17.0M |
| Cash and investments | $257,000 | $707,000 | $974,000 | $2.6M | $3.8M |
| Total debt | $9.4M | $11.0M | $11.2M | $8.7M | $10.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 2, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Aug 22, 2025 | Aug 21, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Jul 10, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Jun 20, 2025 | Mar 31, 2025 |
All 870 Cyanotech Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.